The FDA this week said that Lupin Pharmaceuticals is recalling batches of its Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets.

The company hasn’t seen any illness reports from the Irbesartan and Hydrochlorothiazide medication.

The specific items subject to the recall include all batches of Irbesartan Tablets USP in 75, 150, and 300mg.

Also included are Irbesartan and Hydrochlorothiazide Tablets USP, 150mg/12.5mg and 300mg/12.5mg.

The Irbesartan and Hydrochlorothiazide tablets were available in 30 and 90 count bottles.

The lot numbers subject to the recall include 13262, 14217, 13058, 13768, and 16306.